Matches in Wikidata for { <http://www.wikidata.org/entity/Q83223584> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q83223584 description "article scientifique publié en 2006" @default.
- Q83223584 description "artículu científicu espublizáu en marzu de 2006" @default.
- Q83223584 description "scientific article published on 01 March 2006" @default.
- Q83223584 description "wetenschappelijk artikel" @default.
- Q83223584 description "наукова стаття, опублікована в березні 2006" @default.
- Q83223584 name "[Assessment of the number of cardio- and cerebrovascular events due to rofecoxib (Vioxx) in Germany between 2001 and 2004]" @default.
- Q83223584 name "[Assessment of the number of cardio- and cerebrovascular events due to rofecoxib (Vioxx) in Germany between 2001 and 2004]" @default.
- Q83223584 type Item @default.
- Q83223584 label "[Assessment of the number of cardio- and cerebrovascular events due to rofecoxib (Vioxx) in Germany between 2001 and 2004]" @default.
- Q83223584 label "[Assessment of the number of cardio- and cerebrovascular events due to rofecoxib (Vioxx) in Germany between 2001 and 2004]" @default.
- Q83223584 prefLabel "[Assessment of the number of cardio- and cerebrovascular events due to rofecoxib (Vioxx) in Germany between 2001 and 2004]" @default.
- Q83223584 prefLabel "[Assessment of the number of cardio- and cerebrovascular events due to rofecoxib (Vioxx) in Germany between 2001 and 2004]" @default.
- Q83223584 P1433 Q83223584-C56EC50E-89ED-488A-B009-15DD7899F188 @default.
- Q83223584 P1476 Q83223584-904A63FF-2E9C-4E4B-9975-C69E7006D961 @default.
- Q83223584 P2093 Q83223584-069BD679-32F9-4138-B231-DB017BC03941 @default.
- Q83223584 P2093 Q83223584-36EF52A0-7143-41B0-BC90-468956C89847 @default.
- Q83223584 P2093 Q83223584-85606B30-14D2-4848-988F-444481BE8FF2 @default.
- Q83223584 P2093 Q83223584-BDCD3AB6-2267-44BF-97A9-0BD2709276CB @default.
- Q83223584 P2093 Q83223584-CA8BBF97-9933-4A92-9A75-7838AD12FFB7 @default.
- Q83223584 P304 Q83223584-54934532-8852-4C3B-8952-B31F410C89F2 @default.
- Q83223584 P31 Q83223584-96A2B07B-BE2B-4852-8FF1-F2745C174512 @default.
- Q83223584 P356 Q83223584-93CC9B12-8F24-474F-AACE-BF627A0515D5 @default.
- Q83223584 P433 Q83223584-F8285D3B-8DEB-4A58-AEEE-6473EF0A6CD3 @default.
- Q83223584 P478 Q83223584-C69DEB76-F2E3-40B6-AA13-E933E5E6A3E0 @default.
- Q83223584 P577 Q83223584-1375B354-CB5B-4619-9816-EF5BCC6B15B0 @default.
- Q83223584 P698 Q83223584-CABBDB42-743D-4910-BD8C-C4FBCC31821A @default.
- Q83223584 P921 Q83223584-8123BF1F-2C0D-4753-8135-4DDC6EA4721A @default.
- Q83223584 P356 S00063-006-1044-6 @default.
- Q83223584 P698 16648975 @default.
- Q83223584 P1433 Q11776847 @default.
- Q83223584 P1476 "[Assessment of the number of cardio- and cerebrovascular events due to rofecoxib (Vioxx) in Germany between 2001 and 2004]" @default.
- Q83223584 P2093 "Gisbert W Selke" @default.
- Q83223584 P2093 "Jürgen Klauber" @default.
- Q83223584 P2093 "Peter T Sawicki" @default.
- Q83223584 P2093 "Ralf Bender" @default.
- Q83223584 P2093 "Sven Gutschmidt" @default.
- Q83223584 P304 "191-197" @default.
- Q83223584 P31 Q13442814 @default.
- Q83223584 P356 "10.1007/S00063-006-1044-6" @default.
- Q83223584 P433 "3" @default.
- Q83223584 P478 "101" @default.
- Q83223584 P577 "2006-03-01T00:00:00Z" @default.
- Q83223584 P698 "16648975" @default.
- Q83223584 P921 Q183 @default.